Advanced search×

The Stoke CNEP Saga - how it damaged all involved.

Teresa T Wright

J R Soc Med 103(7):277-82 (2010) PMID 20406828

DOI: 10.1258/jrsm.2010.10k012
Version: za2963e q8za6 q8zbb q8zcc q8zd6 q8zee q8zf0 q8zg1

Similar articles you may find interesting…

  1. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates.
    Kimberly K Page-Shafer, Brandee L BL Pappalardo, ... Michael P MP Busch

    J Clin Microbiol 46(2):499-506 (2008) PMID 18032621 PMCID 2238141

    We evaluate a cross-sectional testing strategy that identifies individuals with acute HCV infection and we estimate HCV incidence. Anti-HCV-negative persons from four populations with various risks, i.e., blood donors, Veterans Administration (VA) patients, young injection drug users (IDU), and olde...
  2. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Ramsey C RC Cheung, Sue S Currie, ...

    J Clin Gastroenterol 42(7):827-34 (2008) PMID 18285716

    AAR, Pohl, and platelet counts s model and APRI performed well for advanced fibrosis in our daily practic...
  3. Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection
    Yonghong Y Li, Monica M Chang, ... John J Sninsky

    J Hepatol 51(4):8 (2009) PMID 19586676 PMCID PMC2883297

    Multiple variants in TLR4 and STXBP5L genes modulate risk of liver fibrosis. These findings are of relevance for understanding the pathogenesis of HCV-induced liver disease in Caucasians and may be extended to other ethnicities as well....
    View PDF